Mouse bone marrow-derived endothelial progenitor cells do not restore radiation-induced microvascular damage

ISRN Cardiology

Volumn 2014, Issue , 2014, Pages

  Seemann, Ingar ^a   Te Poele, Johannes A M ^a   Hoving, Saske ^a   Stewart, Fiona A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; ENDOGLIN; VON WILLEBRAND FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM INJURY; HEART INJURY; HEART MUSCLE FIBROSIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION INJURY; STEM CELL TRANSPLANTATION;

EID: 84922620141     PISSN: 20905580     EISSN: 20905599     Source Type: Journal    
DOI: 10.1155/2014/506348     Document Type: Article

References (30)

1. B. M. Aleman, A. W. van den Belt-Dusebout, M. L. de Bruin et al., "Late cardiotoxicity after treatment for Hodgkin lymphoma," Blood, vol. 109, no. 5, pp. 1878-1886, 2007.
2. S. C. Darby, M. Ewertz, and P. Hall, "Omalizumab for chronic urticaria, "TheNew England Journal ofMedicine, vol. 368, no. 26, pp. 2527-2530, 2013.
3. G. Gyenes, L.E.Rutqvist, A. Liedberg, andT. Fornander, "Longterm cardiac morbidity and mortality in a randomized trial of pre-and postoperative radiation therapy versus surgery alone in primary breast cancer," Radiotherapy & Oncology, vol. 48, no. 2, pp. 185-190, 1998.
4. P.McGale, S. C. Darby, P. Hall et al., "Incidence of heart disease in 35, 000 women treated with radiotherapy for breast cancer in Denmark and Sweden," Radiotherapy & Oncology, vol. 100, no. 2, pp. 167-175, 2011.
5. M. C. Aznar, S.-S. Korreman, A. N. Pedersen, G. F. Persson, M. Josipovic, and L. Specht, "Evaluation of dose to cardiac structures during breast irradiation," The British Journal of Radiology, vol. 84, no. 1004, pp. 743-746, 2011.
6. R. Jagsi, J. Moran, R. Marsh, K. Masi, K. A. Griffith, and L. J. Pierce, "Evaluation of four techniques using intensitymodulated radiation therapy for comprehensive locoregional irradiation of breast cancer," International Journal of Radiation Oncology Biology Physics, vol. 78, no. 5, pp. 1594-1603, 2010.
7. F. Lohr, M. El-Haddad, B. Dobler et al., "Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality," International Journal of Radiation Oncology Biology Physics, vol. 74, no. 1, pp. 73-80, 2009.
8. L. K. Schubert, V. Gondi, E. Sengbusch et al., "Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy," Radiotherapy & Oncology, vol. 100, no. 2, pp. 241-246, 2011.
9. M. Boerma, J. J. Kruse, M. M. van Loenen et al., "Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation," Strahlentherapie und Onkologie, vol. 180, no. 2, pp. 109-116, 2004.
10. K. Gabriels, S. Hoving, I. Seemann, N. L. Visser, M. J. Gijbels et al., "Local heart irradiation of ApoE-/-mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis," Radiotherapy & Oncology, vol. 105, no. 3, pp. 358-364, 2012.
11. I. Seemann, K. Gabriels, N. L. Visser et al., "Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature," Radiotherapy & Oncology, vol. 103, no. 2, pp. 143-150, 2012.
12. S. Schultz-Hector and K. Balz, "Radiation-induced loss of endothelial alkaline phosphatase activity and development of myocardial degeneration: an ultrastructural study," Laboratory Investigation, vol. 71, no. 2, pp. 252-260, 1994.
13. L. B. Marks, X. Yu, R. G. Prosnitz et al., "The incidence and functional consequences of RT-associated cardiac perfusion defects," International Journal of Radiation Oncology Biology Physics, vol. 63, no. 1, pp. 214-223, 2005.
14. B. Seddon, A. Cook, L. Gothard et al., "Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy," Radiotherapy & Oncology, vol. 64, no. 1, pp. 53-63, 2002.
15. J. M. Isner and T. Asahara, "Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization," The Journal of Clinical Investigation, vol. 103, no. 9, pp. 1231-1236, 1999.
16. T. Takahashi, C. Kalka, H. Masuda et al., "Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization," Nature Medicine, vol. 5, no. 4, pp. 434-438, 1999.
17. B. Vailhé, D. Vittet, and J.-J. Feige, "In vitro models of vasculogenesis and angiogenesis," Laboratory Investigation, vol. 81, no. 4, pp. 439-452, 2001.
18. D. W. Losordo and S. Dimmeler, "Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: cell-based therapies," Circulation, vol. 109, no. 22, pp. 2692-2697, 2004.
19. C. Urbich, C. Heeschen, A. Aicher, E. Dernbach, A. M. Zeiher, and S. Dimmeler, "Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells," Circulation, vol. 108, no. 20, pp. 2511-2516, 2003.
20. T.Asahara, H.Masuda, T. Takahashi et al., "Bonemarroworigin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization," Circulation Research, vol. 85, no. 3, pp. 221-228, 1999.
21. S. A. Abdalla and M. Letarte, "Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease," Journal of Medical Genetics, vol. 43, no. 2, pp. 97-110, 2006.
22. S. van den Driesche, C. L. Mummery, and C. J. Westermann, "Hereditary hemorrhagic telangiectasia: an update on transforming growth factor β signaling in vasculogenesis and angiogenesis," Cardiovascular Research, vol. 58, no. 1, pp. 20-31, 2003.
23. H. M. Arthur, J. Ure, A. J. Smith et al., "Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development," Developmental Biology, vol. 217, no. 1, pp. 42-53, 2000.
24. A. Bourdeau, D. J.Dumont, andM. Letarte, "Amurinemodel of hereditary hemorrhagic telangiectasia," The Journal of Clinical Investigation, vol. 104, no. 10, pp. 1343-1351, 1999.
25. S. Post, A. M. Smits, A. J. van den Broek et al., "Impaired recruitment ofHHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance," Cardiovascular Research, vol. 85, no. 3, pp. 494-502, 2010.
26. F. Lebrin and C. L. Mummery, "Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia," Trends in Cardiovascular Medicine, vol. 18, no. 1, pp. 25-32, 2008.
27. K. A. Hinds, J. M. Hill, E. M. Shapiro et al., "Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allowsmagnetic resonance imaging of single cells," Blood, vol. 102, no. 3, pp. 867-872, 2003.
28. Y. Cheng, S. Guo, G. Liu, Y. Feng, B. Yan et al., "Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats," International Journal of Molecular Medicine, vol. 30, no. 4, pp. 870-876, 2012.
29. H. Sekiguchi, M. Ii, K. Jujo, A. Yokoyama, N. Hagiwara, and T. Asahara, "Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells," PLoS ONE, vol. 6, no. 12, Article IDe28639, 2011.
30. R.W.Qi, H. W. Bao, H. H. Yan, G. Dai, M. L. Wei, andQ. Yan, "Purification and growth of endothelial progenitor cells from murine bone marrow mononuclear cells," Journal of Cellular Biochemistry, vol. 103, no. 1, pp. 21-29, 2008.